{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T06:42:15Z","timestamp":1765953735498,"version":"3.48.0"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T00:00:00Z","timestamp":1765929600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010814","name":"Anhui Provincial Department of Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010814","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p>Pediatric abdominal solid tumors mainly include neuroblastoma, nephroblastoma, hepatoblastoma, and rhabdomyosarcoma. Although significant progress has been made in the treatment of these tumors with the combination of surgery and chemotherapy, the treatment outcomes for some patients remain unsatisfactory, and the mortality rate for late-stage patients is still high. The diagnosis and treatment of abdominal solid tumors remain one of the key challenges in pediatric oncology. Numerous studies have found that lipid metabolism abnormalities in tumor tissues and cells lead to a significant increase in lipid levels, promoting cell proliferation, tumor progression, and chemoresistance. This review focuses on the recent advances in the study of lipid metabolism abnormalities in pediatric abdominal solid tumors, aiming to provide a theoretical basis for the treatment of these tumors.<\/jats:p>","DOI":"10.3389\/fped.2025.1727134","type":"journal-article","created":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T06:37:30Z","timestamp":1765953450000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Lipid metabolism abnormalities in pediatric abdominal solid malignant tumors: a comprehensive review"],"prefix":"10.3389","volume":"13","author":[{"given":"Qiang","family":"Hao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenrui","family":"Mi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingting","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aiqin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,12,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"998","DOI":"10.3390\/children11080998","article-title":"Health-related quality of life and mental health of parents of children with pediatric abdominal tumors","volume":"11","author":"Zierke","year":"2024","journal-title":"Children (Basel)"},{"key":"B2","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/s41585-023-00824-0","article-title":"Hallmark discoveries in the biology of wilms tumour","volume":"21","author":"Perotti","year":"2024","journal-title":"Nat Rev Urol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"3031","DOI":"10.1038\/s41467-024-47280-x","article-title":"Single-cell multiomics reveals the interplay of clonal evolution and cellular plasticity in hepatoblastoma","volume":"15","author":"Roehrig","year":"2024","journal-title":"Nat Commun"},{"key":"B4","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12887-024-05360-3","article-title":"Epidemiology and clinical features of childhood malignant solid tumors in a single center in southwest China over 24 years","volume":"25","author":"Li","year":"2025","journal-title":"BMC Pediatr"},{"key":"B5","doi-asserted-by":"publisher","first-page":"e10824","DOI":"10.1136\/jitc-2024-010824","article-title":"Modulating lipid metabolism improves tumor immunotherapy","volume":"13","author":"Ping","year":"2025","journal-title":"J Immunother Cancer"},{"key":"B6","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.jare.2024.02.009","article-title":"Targeting lipid metabolism of macrophages: a new strategy for tumor therapy","volume":"68","author":"Shao","year":"2025","journal-title":"J Adv Res"},{"key":"B7","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s11010-024-04995-1","article-title":"Crosstalk between lipid metabolism and EMT: emerging mechanisms and cancer therapy","volume":"480","author":"Din","year":"2025","journal-title":"Mol Cell Biochem"},{"key":"B8","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.semcancer.2024.12.002","article-title":"Theoretical framework and emerging challenges of lipid metabolism in cancer","volume":"108","author":"Gu","year":"2025","journal-title":"Semin Cancer Biol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1097\/MOH.0000000000000853","article-title":"Unraveling lipid metabolism for acute myeloid leukemia therapy","volume":"32","author":"O'Brien","year":"2025","journal-title":"Curr Opin Hematol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"123022","DOI":"10.1016\/j.biomaterials.2024.123022","article-title":"Targeting lipid metabolism via nanomedicine: a prospective strategy for cancer therapy","volume":"317","author":"Huang","year":"2025","journal-title":"Biomaterials"},{"key":"B11","doi-asserted-by":"publisher","first-page":"3863","DOI":"10.1007\/s12035-024-04501-0","article-title":"Pharmacologically targeting ferroptosis and cuproptosis in neuroblastoma","volume":"62","author":"Liu","year":"2025","journal-title":"Mol Neurobiol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1097\/MOO.0000000000001027","article-title":"Recent developments in olfactory neuroblastoma research","volume":"33","author":"Ghanem","year":"2025","journal-title":"Curr Opin Otolaryngo"},{"key":"B13","doi-asserted-by":"publisher","first-page":"3728","DOI":"10.1038\/s41467-022-31331-2","article-title":"MYCN-driven fatty acid uptake is a metabolic vulnerability in neuroblastoma","volume":"13","author":"Tao","year":"2022","journal-title":"Nat Commun"},{"key":"B14","doi-asserted-by":"publisher","first-page":"8228","DOI":"10.1021\/jacs.3c13165","article-title":"Enzyme-mediated bioorthogonal cascade catalytic reaction for metabolism intervention and enhanced ferroptosis on neuroblastoma","volume":"146","author":"Wang","year":"2024","journal-title":"J Am Chem Soc"},{"key":"B15","doi-asserted-by":"publisher","first-page":"253","DOI":"10.62347\/IDXM4018","article-title":"A prognostic metabolism-related gene signature associated with the tumor immune microenvironment in neuroblastoma","volume":"14","author":"Yu","year":"2024","journal-title":"Am J Cancer Res"},{"key":"B16","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/s41586-023-06878-9","article-title":"7-dehydrocholesterol Is an endogenous suppressor of ferroptosis","volume":"626","author":"Freitas","year":"2024","journal-title":"Nature"},{"key":"B17","doi-asserted-by":"publisher","first-page":"13740","DOI":"10.3390\/ijms232213740","article-title":"GDPD5 related to lipid metabolism is a potential prognostic biomarker in neuroblastoma","volume":"23","author":"Luo","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B18","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1097\/01.JAA.0000000000000165","article-title":"Wilms tumor and associated predisposing syndromes and conditions","volume":"38","author":"Meni","year":"2025","journal-title":"J Am Acad Phys"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e30704","DOI":"10.1002\/pbc.30704","article-title":"Wilms tumor treatment protocol compliance and the influence on outcomes for children in Tanzania","volume":"70","author":"Wesevich","year":"2023","journal-title":"Pediatr Blood Cancer"},{"key":"B20","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1158\/1078-0432.CCR-24-2488","article-title":"Update on surveillance guidelines in emerging wilms tumor predisposition syndromes","volume":"31","author":"Brzezinski","year":"2025","journal-title":"Clin Cancer Res"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.4103\/jcrt.jcrt_1388_21","article-title":"Roles of hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha, a lipid metabolism enzyme, in Wilms tumor patients","volume":"17","author":"Wu","year":"2021","journal-title":"J Cancer Res Ther"},{"key":"B22","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s10528-024-10703-x","article-title":"Identification and validation of lipid metabolism gene FASN-associated miRNA in Wilms tumor","volume":"63","author":"Wang","year":"2025","journal-title":"Biochem Genet"},{"key":"B23","doi-asserted-by":"publisher","first-page":"157","DOI":"10.3390\/diagnostics12010157","article-title":"A metabonomic view on Wilms tumor by high-resolution magic-angle spinning nuclear magnetic resonance spectroscopy","volume":"12","author":"Tasic","year":"2022","journal-title":"Diagnostics"},{"key":"B24","doi-asserted-by":"publisher","first-page":"568","DOI":"10.3892\/ijo.2019.4948","article-title":"Association between different levels of lipid metabolism-related enzymes and fatty acid synthase in Wilms\u2019 tumor","volume":"56","author":"Wang","year":"2020","journal-title":"Int J Oncol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1007\/s12072-024-10750-x","article-title":"Global, regional, and national epidemiology of hepatoblastoma in children from 1990 to 2021: a trend analysis","volume":"19","author":"Guo","year":"2025","journal-title":"Hepatol Int"},{"key":"B26","doi-asserted-by":"publisher","first-page":"e262331","DOI":"10.1136\/bcr-2024-262331","article-title":"Simpson-Golabi-Behmel syndrome type 1 in a neonate with central hepatoblastoma","volume":"18","author":"Rahiman","year":"2025","journal-title":"BMJ Case Rep"},{"key":"B27","doi-asserted-by":"publisher","first-page":"908381","DOI":"10.3389\/fsurg.2022.908381","article-title":"Application of 3D simulation software in chemotherapy and hepatoblastoma surgery in children","volume":"9","author":"Liu","year":"2022","journal-title":"Front Surg"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1002\/hep.31594","article-title":"Deficiency of histone methyltransferase SET domain-containing 2 in liver leads to abnormal lipid metabolism and HCC","volume":"73","author":"Li","year":"2021","journal-title":"Hepatology"},{"key":"B29","doi-asserted-by":"publisher","first-page":"5754592","DOI":"10.1155\/2021\/5754592","article-title":"The mutual inhibition of FoxO1 and SREBP-1c regulated the progression of hepatoblastoma by regulating fatty acid metabolism","volume":"2021","author":"Hu","year":"2021","journal-title":"Mediat Inflamm"},{"key":"B30","doi-asserted-by":"publisher","first-page":"62","DOI":"10.3390\/cells12010062","article-title":"Targeting PCSK9 in liver cancer cells triggers metabolic exhaustion and cell death by ferroptosis","volume":"12","author":"Alannan","year":"2022","journal-title":"Cells-Basel"},{"key":"B31","doi-asserted-by":"publisher","first-page":"e778","DOI":"10.1002\/ctm2.778","article-title":"The N6-methyladenosine modification enhances ferroptosis resistance through inhibiting SLC7A11 mRNA deadenylation in hepatoblastoma","volume":"12","author":"Liu","year":"2022","journal-title":"Clin Transl Med"},{"key":"B32","doi-asserted-by":"publisher","first-page":"747","DOI":"10.12122\/j.issn.1673-4254.2021.05.16","article-title":"Effect of fatty acid synthase gene silencing on lipid metabolism and biological behaviors of human hepatoblastoma HepG2 cells","volume":"41","author":"Huang","year":"2021","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"key":"B33","doi-asserted-by":"publisher","first-page":"115241","DOI":"10.1016\/j.fct.2025.115241","article-title":"Impact of endocrine disruptors on key events of hepatic steatosis in HepG2 cells","volume":"197","author":"Grosso","year":"2025","journal-title":"Food Chem Toxicol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"a41583","DOI":"10.1101\/cshperspect.a041583","article-title":"Developmental heterogeneity of rhabdomyosarcoma","volume":"15","author":"Stevens","year":"2025","journal-title":"Csh Perspect Med"},{"key":"B35","doi-asserted-by":"publisher","first-page":"161928","DOI":"10.1016\/j.jpedsurg.2024.161928","article-title":"Identifying novel genetic markers in pediatric rhabdomyosarcoma","volume":"60","author":"Xu","year":"2025","journal-title":"J Pediatr Surg"},{"key":"B36","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s00428-024-03961-y","article-title":"Rhabdomyosarcoma in children and young adults","volume":"486","author":"Chen","year":"2025","journal-title":"Virchows Arch"},{"key":"B37","doi-asserted-by":"publisher","first-page":"e31541","DOI":"10.1002\/pbc.31541","article-title":"Evidence-based surgical guidelines for treating children with rhabdomyosarcoma","volume":"72","author":"Abdelhafeez","year":"2025","journal-title":"Pediatr Blood Cancer"},{"key":"B38","doi-asserted-by":"publisher","first-page":"4081","DOI":"10.7150\/jca.41736","article-title":"The expression of perilipin family proteins can be used as diagnostic markers of liposarcoma and to differentiate subtypes","volume":"11","author":"Zhang","year":"2020","journal-title":"J Cancer"},{"key":"B39","doi-asserted-by":"publisher","first-page":"10975","DOI":"10.1007\/s00432-023-04930-9","article-title":"Antitumor activity of natural pigment violacein against osteosarcoma and rhabdomyosarcoma cell lines","volume":"149","author":"Milosevic","year":"2023","journal-title":"J Cancer Res Clin"},{"key":"B40","doi-asserted-by":"publisher","first-page":"6442","DOI":"10.1002\/cam4.4185","article-title":"Inhibition of lipid metabolism exerts antitumor effects on rhabdomyosarcoma","volume":"10","author":"Miyagaki","year":"2021","journal-title":"Cancer Med US"},{"key":"B41","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1002\/ijc.32496","article-title":"Targeting ferroptosis in rhabdomyosarcoma cells","volume":"146","author":"Dachert","year":"2020","journal-title":"Int J Cancer"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2025.1727134\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T06:37:39Z","timestamp":1765953459000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2025.1727134\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,17]]},"references-count":41,"alternative-id":["10.3389\/fped.2025.1727134"],"URL":"https:\/\/doi.org\/10.3389\/fped.2025.1727134","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,17]]},"article-number":"1727134"}}